Symptoms, Viral Loads, and Rebound among Coronavirus Disease 2019 (COVID-19) Outpatients Treated with Nirmatrelvir/Ritonavir Compared with Propensity Score–Matched Untreated Individuals Sarah E. Smith-Jeffcoat , Jessica E. Biddle , H. Keipp Talbot , Kerry Grace Morrissey , Melissa S. Stockwell , Yvonne Maldonado , Huong Q. McLean , Katherine D. Ellingson , Natalie M. Bowman , Edwin Asturias , Alexandra M. Mellis , Sheroi Johnson , Hannah L. Kirking , Melissa A. R. Rolfes , Vanessa Olivo , Lori Merrill , Steph Battan-Wraith , Ellen Sano , Son H. McLaren , Celibell Y. Vargas , Sara Goodman , Clea C. Sarnquist , Prasanthi Govindaranjan , Joshua G. Petrie , Edward A. Belongia , Karla Ledezma , Kathleen Pryor , Karen Lutrick , Ayla Bullock , Amy Yang , Quenla Haehnel , Suchitra Rao , Yuwei Zhu , Jonathan Schmitz , Kimberly Hart , Carlos G. Grijalva , Phillip P. Salvatore CLINICAL INFECTIOUS DISEASES（2023）
Key words
SARS-CoV-2, antiviral treatment, rebound, symptoms, viral loads
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
